Literature DB >> 28561210

Cardiac Etiologies of Hydrops Fetalis.

Shi-Min Yuan1.   

Abstract

Cardiac etiologies of hydrops fetalis have been a topic of concern due to challenging perinatal management. The common cardiac etiologies leading to hydrops fetalis include structural cardiac anomalies, cardiac dysrhythmias, cardiac tumors, cardiomyopathy and myocarditis. The mechanisms of cardiogenic hydrops fetalis may be: 1) elevation of atrial pressure and volume overload, 2) decrease of cardiac output, and 3) development of congestive heart failure. The diagnosis of hydrops fetalis was usually made at 19-36 gestational weeks, when ultrasound is a highly effective diagnostic method. Intrauterine interventions for certain congenital heart defects, maternal transplacental or direct fetal medications and fetal pacing placement for cardiac arrhythmias, and fetal or postnatal tumor resections are important progressions of etiologic treatment for hydrops fetalis. Treatment strategies for hydrops fetalis per se are usually ultrasound-guided pericardiocentesis and feto-amniotic shunting, whereas reaccumulation may require further interventions in utero or postnatally. Hydrops fetalis often carries a poor prognosis, and mortality remains high. Current developments in the management of hydrops fetalis should encourage physicians to attempt further fetal interventions. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2017        PMID: 28561210     DOI: 10.1055/s-0042-123825

Source DB:  PubMed          Journal:  Z Geburtshilfe Neonatol        ISSN: 0948-2393            Impact factor:   0.685


  2 in total

1.  Congenital heart disease in a patient with COVID-19 infection during early pregnancy: a case report.

Authors:  Mohamed Ali Abdelkader; Hamed Mohamed Abbas; Ibrahim Mohamed Aboelkhair; Aliaa Salah Ali Alafify; Basim Abdelfattah Elgazzar; Mai Salah El-Din Koura
Journal:  Egypt Heart J       Date:  2022-08-27

2.  Complete resolution of arrhythmia-induced hydrops fetalis in utero.

Authors:  Monisha Narayanan; Sypara Dhuka; Srilatha Alapati; Robert P Kauffman
Journal:  BMJ Case Rep       Date:  2020-10-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.